Cambridge Interventional develops, manufactures, and supports the use of innovative radiofrequency ablation (RFA) devices. RFA is a minimally-invasive technology used to treat benign, malignant, and abnormal tissue in the liver, kidneys, bones, lungs, uterus, and thyroid using image-guided probes. Designed with clinicians in mind, our system combines advanced technology with an intuitive, user-friendly interface for a seamless ablation experience.
At Cambridge, we empower clinicians and improve patient lives through precision, versatility, and innovation. We continue to work toward a future where minimally invasive, image-guided ablation is the global standard for treating abnormal tissues.
Our mission is to design and manufacture high-quality, intuitive, and cost-effective interventional devices for the treatment of cancer, thyroid disorders, and other medical issues.
Through research, engineering, and medical education, we aim to advance therapeutic efficacy, safety, and applicability worldwide.
We strive to expand our business with ethical practices, staff development, and outstanding customer service.
For over 70 years, the team at Cambridge Interventional has been a pioneer in developing and manufacturing Class I, II, and III radiofrequency devices used to treat millions of patients.
As a global provider of RFA technology across multiple clinical areas, we shape the future of thermal ablation every day. Our precision-crafted RFA system has proudly received FDA 510(k) clearance, the CE mark for marketing in the EU, and other international regulatory approvals.
Founded by Dr. Eric Cosman Jr, Cambridge Interventional offers the most powerful and easiest to use system for radiofrequency thyroid ablation.
Cosman Medical markets innovative RF devices for neurological ablation in over
70 countries around the world.
Professor Eric Cosman develops the Radionics® Cool-tip®, the first cooled RF system for percutaneous tissue ablation, used for the first thyroid treatments.1,2
Radionics® founder Bernard Cosman develops the first RF generator marketed for use in medicine.4
Schedule a discovery call to learn how Cambridge’s RFA technology is guiding the next generation of radiofrequency ablation.
